News

Events

June,2023

NanoMedSyn will participate to the International Symposium on Inorganic  and Environmental Materials ISIEM2023 in Montpellier, France. The symposium will focus...
Lire la suite
Events

November, 2022

The 3rd Immune-Oncology World Congress Immuno-Oncology2022 will focus on the latest developments and findings in immuno-oncology therapy as well as targeted...
Lire la suite
Events

October, 2022

Invest in Biomed, 7th edition. For innovative companies with high potential in healthtech, Eurobiomed continues its support.
Lire la suite
Events

October,2022

Day of the cluster : Biotherapy Innovation Occitanie October 13, 2022 in Montpellier https://www.agence-adocc.com/biotherapie-innovation-occitanie/  
Lire la suite
Events

June, 2022

NanoMedSyn is co-organiser of  the 2nd Symposium on delivery and target for pediatric tumors, on 23-24th June in Switzerland (Schwarzsee)....
Lire la suite
Events

June, 2022

10th Antibody Industrial Symposium 2022 We are proud to announce our participation to the 10th Antibody Industrial Symposium 2022 (AIS2022)...
Lire la suite
Events

October, 2021

NanoMedSyn is classified as a DEEPTECH company by Bpifrance for its Innovative Therapeutic Targeting Technology.
Lire la suite
Events

July, 2021

NanoMedSyn has signed a research agreement with the French National Research Agency within the framework of the "Plan France Relance...
Lire la suite
Events

June, 2021

NanoMedSyn has been distinguished for its Growth Path by Bpifrance and joins the "Excellence" community.
Lire la suite
Events

December, 2020

NanoMedSyn has signed a 3-year Innovation Contract with the Occitanie Region for a "Research and Development of New Targeted Drugs"...
Lire la suite
Events

July, 2020

Dr. Marcel Garcia, co-founder and Scientific Director, is appointed President and Scientific Director of NanoMedSyn by the General Assembly. This...
Lire la suite
Events

June, 2019

This article demonstrates the involvement of acid phosphatases in the higher efficacy of AMFA-labelled enzyme therapy. J Cell Mol Med....
Lire la suite
Events

March, 2018

Shire and NanomedSyn enter into research agreement for potential lysosomal storage disorder treatment. This collaboration was stopped in September 2019....
Lire la suite
Events

October, 2017

NanoMedSyn  develops an efficient  treatment for refractory Pompe disease published by Journal of Controlled Release. J Control Release 2017, 269:15-23.
Lire la suite
Events

October, 2016

First NanoMedSyn studies to improve Pompe disease treatment published by Angewandte. Angew Chem Int Ed Engl. 2016 DOI: 10.1002/anie.201607824R2  
Lire la suite
Events

September, 2016

Orphan designation was granted by European commission for the recombinant GAA-AMFA developed by NanoMedSyn for the treatment of Pompe's disease....
Lire la suite
Events

September, 2016

Lire l'article complet
Lire la suite
Events

June, 2016

Le Grand Prix « Sciences de la Vie » est décerné à NanoMedSyn au Sénat lors de la finale du 16e concours...
Lire la suite
Events

November, 2015

http://www.rare2015.com/index.php      
Lire la suite
1 2